Ric Scalzo Institute of Botanical Research and Kelai Pharmaceutical Announce Research Partnership
Kava Research Begins at Biosafety Level 2 and Analytical Plant Chemistry Labs
- Kelai Pharmaceutical specializes in the development of advanced drug delivery (ADD) technologies that utilize natural compounds to create safer, more effective, and innovative therapies for addiction, mental health disorders, and related conditions
"We are particularly excited about starting the discovery partnership with the Ric Scalzo Institute for Botanical Research that builds on a rich traditional use of Kava. - We see this as the platform for accelerating our forward-looking research and discoveries around Kava," said Jacqueline Jacques, ND, Chief Executive Officer, Kelai Pharmaceutical.
- When considering botanical material for research, the team analyzes the plant's background, supply chain, ethnobotanical history, and relevant clinical data.
- For more information on the Ric Scalzo Institute for Botanical Research, visit scnm.edu/research.